Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Breast Neoplasms 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sexually Transmitted Diseases 1Ovarian Cysts 1Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1High-grade Anal Intraepithelial Neoplasia 1HIV Infections 1Endometriosis 1Condylomata Acuminata 1Benign Ovarian Tumor 1Anus Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Electrocoagulation × Clear all
NCT02835391 2017-09-01

PerClot Compared to Usual Care in Gynaecology Procedures

CryoLife Europa

Phase NA Completed
90 enrolled
Gynecologic

Endometriosis, Leiomyoma, Menorrhagia, Neoplasms, Ovarian Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡